NG-350A clinical trials

NG-350A plus chemoradiotherapy for locally advanced rectal cancer

This study is testing a new gene therapy, NG-350A, along with standard chemotherapy and radiotherapy, for people with locally advanced rectal cancer. It aims to see how well it works and if it's safe, by helping the body's immune system fight cancer cells.